RJF:NYSERaymond James Financial, Inc. Analysis
Data as of 2026-03-10 - not real-time
$151.43
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Raymond James Financial trades at a trailing P/E of 14.8, well below the industry average of 17.4, and its DCF‑derived fair value of $150.8 is only marginally above the current price of $151.4, implying modest undervaluation with an upside potential of roughly 22% to intrinsic value. The stock’s fundamentals are solid: a low payout ratio of 19.9%, strong cash balances, and a ROE of 17% support dividend sustainability. Technical indicators are mixed – the price sits beneath the 20‑day, 50‑day, and 200‑day SMAs, the RSI is at 38 (near oversold), and the MACD histogram is negative, suggesting short‑term bearish pressure. Short interest has risen to 5.3% of float, with a cover ratio of 4.9 days, and recent headlines cite concerns over AI advisory models and an 8.8% intraday slide, adding a near‑term catalyst for caution. However, the company’s revenue growth of 5.7%, forward earnings expansion, and a “Buy” consensus from twelve analysts point to a longer‑run upside, especially given a target median price of $184.5. The market sentiment is currently “Extreme Greed,” which may be pricing in optimistic expectations already. Overall, the blend of undervaluation, sustainable dividend, and strong balance sheet makes RJF a compelling entry point, while technical softness and short‑term headwinds advise a measured approach.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages and bearish MACD
- Rising short interest and AI‑related concerns
- Strong dividend sustainability offering downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers (PE 14.8 vs 17.4)
- Upside to DCF fair value and analyst target price
- Robust cash position and low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent revenue and earnings growth
- Stable business model across wealth management, capital markets, and banking
- Low geographic concentration and manageable regulatory exposure
Key Metrics & Analysis
Financial Health
Revenue Growth5.70%
Profit Margin14.76%
P/E Ratio14.8
ROE17.12%
ROA2.45%
Debt/Equity46.26
P/B Ratio2.4
Op. Cash Flow$1.6B
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI38.3
Support$147.12
Resistance$174.14
MA 20$156.18
MA 50$163.33
MA 200$161.52
MACDBearish
VolumeDecreasing
Fear & Greed Index79.64
Valuation
Fair Value$150.80
Target Price$184.83
Upside/Downside22.06%
GradeUndervalued
TypeBlend
Dividend Yield1.43%
Risk Assessment
Beta1.01
Volatility36.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.